Cargando…
Transplantation for Primary Sclerosing Cholangitis: Outcomes and Recurrence
Primary sclerosing cholangitis (PSC) is characterized by inflammation of the whole bile duct system. Liver transplantation is only approved as a curative treatment when it comes to end-stage liver disease. The aim of our study was to assess morbidity, survival rates and PSC recurrence and the impact...
Autores principales: | Saner, Fuat H., Frey, Alexandra, Stüben, Björn-Ole, Hoyer, Dieter P., Willuweit, Katharina, Daniel, Martina, Rashidi-Alavieh, Jassin, Treckmann, Jurgen W., Schmidt, Hartmut H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219380/ https://www.ncbi.nlm.nih.gov/pubmed/37240511 http://dx.doi.org/10.3390/jcm12103405 |
Ejemplares similares
-
Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients–A Single-Center Experience
por: Rashidi-Alavijeh, Jassin, et al.
Publicado: (2021) -
Risk Factors for High Mortality on the Liver Transplant Waiting List in Times of Organ Shortage: A Single-Center Analysis
por: Husen, Peri, et al.
Publicado: (2019) -
Liver Transplantation From Donors With a History of Malignancy: A Single-Center Experience
por: Benkö, Tamas, et al.
Publicado: (2017) -
Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022) -
Real-World Administration of Once-Daily MeltDose(®) Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation
por: Willuweit, Katharina, et al.
Publicado: (2020)